INOVIQ Exosome Diagnostic Solutions
Summary | Next generation diagnostic solutions advancing towards key milestones
For personal use only
20
20
2
3
4
Innovative
Company
Patented
Technology
Strong
Pipeline
Compelling
Results
Focused on next-gen diagnostic
and exosome solutions to
improve health outcomes in
cancer and other diseases
Proprietary SubB2M & NETS
technologies with multiple
diagnostic and therapeutic
applications
Deep pipeline
for detection of common and/or
deadly cancers
Data for SubB2M and exosome-
based tests demonstrating earlier
and more accurate detection for
breast & ovarian cancers
Commercialized
Products
Products in-market for
exosome isolation
and bladder cancer detection
6
7
Partnering for
Growth
Commercialisation through
partnering to deliver solutions to
global markets
Experienced
Leadership
Track record in healthcare
leadership, exosome science,
diagnostic development and
commercialisation
8
Funding our
Future
Cash of $6.3m as at 30 Sep 23 to
fund operations and pipeline
development
INOVIQView entire presentation